The good news is that the number of deaths from colorectal cancer has been decreasing over the last 15 years1. In part, this could be because more people are going for regular screening, which can detect colorectal cancers early2. Treatment for colorectal cancer has also improved. This m...
Screening for cancer: colonoscopy starting at 10–15 years of age Treatment: prophylactic colectomy (proctocolectomy or total colectomy), usually by age 20 Indications for colectomy in FAP : Elective Suspected CRC Presence of colonic dysplasia or neoplasia Significant increase in polyp number during...
A guidance statement from the American College of Physicians on "Screening for colorectal cancer" (Qaseem et al, 2012) stated that “The screening interval for average-risk adults older than 50 years is 10 years for colonoscopy; 5 years for flexible sigmoidoscopy, double-contrast barium enema (...
Fletcher RH. Test for screening for colorectal cancer: stool tests, radiologic imaging and endoscopy. En: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2012. 90 EVIDENCIA - Actualizacion en la Practica Ambulatoria - Julio/Septiembre 2012 - Disponible en internet: www.evidencia.org...
Disclosures:The authors report no relevant financial disclosures. Doubeni reports membership on the USPSTF, as well as an author role with UpToDate. Jordan J. Karlitz, MD This is an important study because of the debate over whether colorectal cancer screening should begin at ...
Colorectal cancer (CRC), which is one of the most frequently seen cancers worldwide, is also one of the major causes of cancer-related deaths. With the advancement of diagnostic technology and effective implementation of screening programs, the detection and surgical treatment of CRCs at a resecta...
Of all CRC cases diagnosed each year, 25% present some characteristic indicating hereditary cancer susceptibility. Of these, 5% correspond to Lynch syndrome, 1% to polyposis and the rest to what could be called ‘family aggregations’. The identification of these clinical pictures has a high impact...
In the USA, CRC is the third most commonly diagnosed cancer in both men and women. It is caused by genetic components and potential environmental factors such as consumption of processed meat, red meat, animal fats, low fiber intake, and obesity. Despite the utilization of effective screening ...
The present invention provides a novel complex for use in the prevention and/or treatment of colorectal cancer, the complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein the components a)-c) are cov...
The efficacy of colorectal cancer (CRC) screening is dependent on participation and subsequent adherence to surveillance. The internet increasingly is used for health information and is important to support decision making. We evaluated the accuracy, quality, and readability of online information on CRC...